Genomic surveillance reveals that the dengue 2 virus lineage responsible for the 2023-2024 epidemic in the French Caribbean Islands is resistant to Mosnodenvir
Hawa Sophia Bouzidi, S. SEN, Géraldine Piorkowski, Laura Pezzı, Nazlı Ayhan, Albin Fontaine, Thomas Canivez, Manon Geulen, Rayane Amaral, Gilda Grard, Guillaume André Durand, Xavier Nicolas de Lamballerie, Franck Touret, Raphaëlle Klitting
The paper identifies a mutation in dengue virus genomes from the 2023-2024 French Caribbean epidemic that confers resistance to the anti-dengue compound mosnodenvir.
Nature Communications · Oct 9, 2024Peer-reviewedMicrobiology